ArticleStem cells international2021

Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy.

Seok Jong Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.